Dr Robert (Bob) Muid worked in education for over three decades - as researcher, teacher and manager. He started his career in 1970 at the pharmaceutical manufacturers May & Baker Ltd, in the biochemistry research laboratories. He joined the staff at University College London, Pharmacology Department in 1974 working as an immunopharmacology technician with Dr M.Maureen Dale (of Rang & Dale fame). He later became a senior experimental officer and obtained his PhD in the Department of Pharmacology.
In1994 he took over the post of Pharmacology Department Manager, under the headships of Prof. David A. Brown, FRS and then Prof. Trevor G. Smart, and had responsibility for the finance, support staff, buildings, website and computing until the disestablishment of the Department in 2008.
Apart from his departmental duties he worked closely with the Information Systems Division and was reponsible for the deployment of University College London's computer anti-virus software and from August 2006 was the administrator for the plagiarism detection service, Turnitin, at UCL.
After the disestablishment of the Pharmacology Department in 2008 he became IT Manager for the Division of Biosciences within the Faculty of Life Sciences until his retirement in 2010.
From 1996 until the present he also managed G23 Instruments.
Bob Muid holds a Ph.D. in Immunopharmacology from the University of London (UCL). The emphasis of his prior research was the role of human neutrophils (white blood cells) in both killing tumour cells and the auto-immune disease rheumatoid arthritis via the generation of toxic oxygen radicals. He has published multiple peer-reviewed manuscripts on the topic.
Some antique publications which illustrate his research interests:
- R.E. Muid, B. Twomey & M.M. Dale (1992) The neutrophil leukocyte. In Textbook of Immunopharmacology, Eds. M.M. Dale, J.C. Foreman & T-P.D. Fan, III edition, Pub. Blackwell Scientific.
- R.E. Muid, M.M. Dale, P.D. Davis, L.H. Elliott, C.H. Hill, H. Kumar, G. Lawton, B.M. Twomey, J. Wadsworth, S.E. Wilkinson & J.S. Nixon (1991) A novel conformationally restricted protein kinase C inhibitor, Ro 31-8425, inhibits human neutrophil superoxide generation by soluble, particulate and post-receptor stimuli. FEBS Lett., 293, 169-172. [PubMed]
- B. Twomey, R.E. Muid, J.S. Nixon, A.D. Sedgwick, S.E. Wilkinson & M.M. Dale (1990) The effect of new potent selective inhibitors of protein kinase C on the neutrophil respiratory burst. Biochem. Biophys. Res. Commun., 171, 1087-1092. [PubMed]
- B. Twomey, R.E. Muid & M.M. Dale (1990) The effect of putative protein kinase C inhibitors, K252A and staurosporine, on the human neutrophil respiratory burst activated by both receptor and post-receptor mechanisms. Br. J. Pharmacol., 100, 819-825. [Article]
- B. Twomey, R.E. Muid & M.M. Dale (1989) The potentiation of human neutrophil superoxide generation by sodium meclofenamate. Br. J. Pharmacol., 98, 671P.
- R.E. Muid, B. Twomey & M.M. Dale (1988) The effect of inhibition of both diacylglycerol metabolism and phospholipase A2 activity on superoxide generation by human neutrophils. FEBS Lett., 234, 235-240. [PubMed]
- R.E. Muid, A. Penfield & M.M. Dale (1987) The diacylglycerol kinase inhibitor, R59022, enhances the superoxide generation from human neutrophils induced by stimulation of fMet-Leu-Phe, IgG and C3b receptors. Biochem. Biophys. Res. Commun., 143, 630-637. [PubMed]
- M.M. Dale, R.E. Muid & H.K. Wilson (1984) The effect of inhibitors of macromolecular synthesis on neutrophil-mediated antibody-dependent cellular cytotoxicity: exacerbation by mitomycin C. Int. J. Immunopharmac., 6, 279-285. [PubMed]
- M.M. Dale, R.E. Muid & H.K. Wilson (1983) Neutrophil-mediated antibody-dependent cellular cytotoxicity: morphological concomitants of 51Cr-release. Immunology, 49, 401-403. [Article]
- M.M. Dale & R.E.Muid (1978) A mammalian muscle with the pharmacological characteristics of slow tonic muscle. J. Pharm. Pharmac., 30, 297-300. [PubMed]
- M.M. Dale & R. Muid (1976) A simple in vitro preparation of mammalian tissue exhibiting properties of slow tonic skeletal muscle. Br. J. Pharmacol., 58, 288-289P. [Poster]